INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 121 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $26,306 | +31.6% | 124,968 | 0.0% | 0.00% | – |
| Q1 2023 | $19,995 | -71.2% | 124,968 | 0.0% | 0.00% | – |
| Q4 2022 | $69,357 | -53.5% | 124,968 | 0.0% | 0.00% | – |
| Q3 2022 | $149,000 | +204.1% | 124,968 | +62.3% | 0.00% | – |
| Q2 2022 | $49,000 | -61.4% | 76,991 | -31.1% | 0.00% | – |
| Q1 2022 | $127,000 | -49.6% | 111,783 | 0.0% | 0.00% | – |
| Q4 2021 | $252,000 | -34.2% | 111,783 | -0.3% | 0.00% | – |
| Q3 2021 | $383,000 | -93.3% | 112,100 | -74.8% | 0.00% | -100.0% |
| Q2 2014 | $5,676,000 | +7.2% | 445,500 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $5,297,000 | -11.9% | 445,500 | +2.4% | 0.00% | 0.0% |
| Q4 2013 | $6,010,000 | -9.7% | 435,200 | +14.0% | 0.00% | -25.0% |
| Q3 2013 | $6,659,000 | +41.3% | 381,600 | +31.5% | 0.00% | +33.3% |
| Q2 2013 | $4,714,000 | – | 290,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 7,866,108 | $25,408,000 | 4.32% |
| Nine Chapters Capital Management LLC | 91,500 | $296,000 | 0.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,969,225 | $6,361,000 | 0.24% |
| Orbimed Advisors | 3,250,300 | $10,498,000 | 0.12% |
| PINNACLE ASSOCIATES LTD | 1,306,679 | $4,221,000 | 0.08% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 810,232 | $2,617,000 | 0.07% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 270,417 | $873,000 | 0.06% |
| Rock Springs Capital Management LP | 270,000 | $872,000 | 0.05% |
| ALGERT GLOBAL LLC | 39,876 | $129,000 | 0.04% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 391,671 | $1,265,000 | 0.03% |